<?xml version="1.0" encoding="UTF-8"?>
<p>Melatonin has been shown to be clinically useful in sepsis (
 <xref rid="B43" ref-type="bibr">43</xref>), where the clinical features parallel those of COVID-19 viral infection; moreover, melatonin has been demonstrated to relieve many of the symptoms of other viral infections (
 <xref rid="B17" ref-type="bibr">17</xref>â€“
 <xref rid="B21" ref-type="bibr">21</xref>, 
 <xref rid="B48" ref-type="bibr">48</xref>). Given the current worldwide situation and in consideration of evidence-based medicine, the efficacy of melatonin and its high pharmacological safety profile supports its use in the treatment of infectious diseases, such as COVID-19. Melatonin can also be useful as a supplement with other treatment (hydroxychloroquine/chloroquine, lopinavir, remidisvir, etc).
</p>
